» Articles » PMID: 23138985

Chronic Kidney Disease in Adolescent and Adult Patients with Phenylketonuria

Overview
Publisher Wiley
Date 2012 Nov 10
PMID 23138985
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: A lifelong phenylalanine-restricted diet with supplementation of a phenylalanine-free amino acid formula is recommended in patients with phenylketonuria (PKU). The effect of a long-term PKU diet on renal function and blood pressure has not been investigated yet.

Design: We analyzed renal function in 67 patients with PKU, aged 15-43 years, by measuring glomerular filtration rate (GFR) and effective renal plasma flow by isotope clearance ((51)Cr-EDTA, (123)J-Hippuran), estimated GFR, blood retention parameters, urinary protein and electrolyte excretion. Renal ultrasound and 24 h ambulatory blood pressure monitoring were performed additionally. Patients were divided into three groups according to their: 1) current diet (CD), i.e., daily protein intake: ICD <0.8 g/kg, IICD 0.8-1.04 g/kg, IIICD >1.04 g/kg; 2) life-long diet time (LDT), i.e., cumulative years of life in which daily protein intake exceeded dietary recommendations: ILDT <15 years, IILDT 15-19 years, IIILDT >19 years.

Results: GFR was decreased in 19 % of the patients. With increasing protein intake, GFR decreased significantly (ICD 111 ml/min; IICD 105 ml/min; IIICD 99 ml/min. ILDT 112 ml/min; IILDT 103 ml/min; IIILDT 99 ml/min). Proteinuria was detected in 31 %, microalbuminuria in 7 %, and hypercalciuria in 23 % of the patients. 23 % of the patients had arterial hypertension, and 41 % revealed a nocturnal non-dipping status.

Conclusions: In patients with PKU on a lifelong diet we could detect impaired renal function in 19 %, proteinuria in 31 %, and arterial hypertension in 23 %. Thus, chronic kidney disease may develop in PKU patients, and routine renal function tests should be performed during long-term follow-up.

Citing Articles

Large Variations in Phenylalanine Concentrations Associate Adverse Cardiac Remodelling in Adult Patients With Phenylketonuria-A Long-Term CMR Study.

Tanacli R, Doeblin P, Faragli A, Hassel J, Stehning C, Plockinger U J Cachexia Sarcopenia Muscle. 2025; 16(1):e13667.

PMID: 39797500 PMC: 11724155. DOI: 10.1002/jcsm.13667.


Novel Metabolites Associated with Decreased GFR in Finnish Men: A 12-Year Follow-Up of the METSIM Cohort.

Fernandes Silva L, Vangipurapu J, Oravilahti A, Laakso M Int J Mol Sci. 2024; 25(18).

PMID: 39337529 PMC: 11432478. DOI: 10.3390/ijms251810044.


Impact of Phenylketonuria on the Serum Metabolome and Plasma Lipidome: A Study in Early-Treated Patients.

Weerd J, van Wegberg A, Boer T, Engelke U, Coene K, Wevers R Metabolites. 2024; 14(9).

PMID: 39330486 PMC: 11434371. DOI: 10.3390/metabo14090479.


Amino Acid Profile Alterations in Phenylketonuria: Implications for Clinical Practice.

Matuszewska E, Matysiak J, Kaluzny L, Walkowiak D, Plewa S, Dus-Zuchowska M Metabolites. 2024; 14(7).

PMID: 39057720 PMC: 11279192. DOI: 10.3390/metabo14070397.


Expert Consensus on the Long-Term Effectiveness of Medical Nutrition Therapy and Its Impact on the Outcomes of Adults with Phenylketonuria.

Rocha J, Ahring K, Bausell H, Bilder D, Harding C, Inwood A Nutrients. 2023; 15(18).

PMID: 37764724 PMC: 10536918. DOI: 10.3390/nu15183940.


References
1.
Brenner B, Meyer T, Hostetter T . Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N Engl J Med. 1982; 307(11):652-9. DOI: 10.1056/NEJM198209093071104. View

2.
Macdonald A, Rocha J, van Rijn M, Feillet F . Nutrition in phenylketonuria. Mol Genet Metab. 2011; 104 Suppl:S10-8. DOI: 10.1016/j.ymgme.2011.08.023. View

3.
Burgard P, Bremer H, Buhrdel P, Clemens P, Monch E, Przyrembel H . Rationale for the German recommendations for phenylalanine level control in phenylketonuria 1997. Eur J Pediatr. 1999; 158(1):46-54. DOI: 10.1007/s004310051008. View

4.
Guy M, Borzomato J, Newall R, Kalra P, Price C . Protein and albumin-to-creatinine ratios in random urines accurately predict 24 h protein and albumin loss in patients with kidney disease. Ann Clin Biochem. 2009; 46(Pt 6):468-76. DOI: 10.1258/acb.2009.009001. View

5.
Ribas G, Sitta A, Wajner M, Vargas C . Oxidative stress in phenylketonuria: what is the evidence?. Cell Mol Neurobiol. 2011; 31(5):653-62. PMC: 11498541. DOI: 10.1007/s10571-011-9693-2. View